HKU Scholars Hub: Browsing DSpace

Browsing "Li Ka Shing Faculty of Medicine: Conference papers" by Author chan, p

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 25 next >

Title	Author(s)	Issue Date
The cardioprotective effect of isosteviol on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes Proceeding/Conference:World Congress on Heart Disease Annual Scientific Session 2012	Wong, KL Chao, CC Cheung, CW Chan, P Cheng, TH Leung, YM	2012
Chemoprophylaxis in colorectal cancer: Current concepts and a practical algorithm for use Proceeding/Conference:Expert Opinion on Investigational Drugs	Tan, VPY Chan, P Hung, IFN Pang, R Wong, BCY	2010
Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: results of a pilot phase II study Proceeding/Conference:European Journal of Cancer	Yau, T Wong, H Chan, P Yao, T Cheung, TT Fan, ST Poon, RTP	2012
Cost-effectiveness analysis of colorectal cancer screening in Hong Kong Proceeding/Conference:Research Postgraduate Symposium, RPS 2011	Wong, KH Lam, CLK Law, WL Poon, JTC Chan, P McGhee, S Fong, DYT Kwong, DLW Tsang, JWH	2011
Efficacy and safety of single agent sunitinib in treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: a prospective, open-label, phase II study Proceeding/Conference:Liver Cancer	Yau, TCC Leung, RCY Wong, HYH Chiu, JWY Chan, P Tang, YF Cheung, TT Pang, RWC Fan, ST Poon, RTP	2013
Efficacy and safety of single-agent sunitinib in treating advanced hepatocelluar carcinoma patients after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Annals of Oncology	Yau, TCC Leung, RCY Wong, H Chiu, J Chan, P Pang, RWC Fan, ST Poon, RTP	2011
Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Journal of Clinical Oncology	Yau, T Leung, RC Wong, H Chiu, J Chan, P Pang, R Fan, ST Poon, RTP	2011
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma Proceeding/Conference:Oncology	Yau, T Chan, P Wong, H Ng, KK Chok, KSH Cheung, TT Lam, V Epstein, RJ Fan, ST Poon, RTP	2007
Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology	Wong, H Yau, CC Yao, T Tang, V Chan, P Chiu, J Fan, ST Poon, R	2010
Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract) Proceeding/Conference:International Meeting Hepatocellular Carcinoma, IMHCC 2011	Yau, TCC Chan, P Cheung, FY Lee, AS Yau, TK Choo, SP Toh, HC Leung, AK Wong, JS Wong, S Lau, J Pang, RWC Fan, ST Poon, RTP	2011
Epidemiology of Community-Acquired Pneumonia in Hong Kong: a prospective observational study Proceeding/Conference:Canadian Journal of Emergency Medicine	Man, SY Chu, K Man, CY Lee, N Ip, M Galvani, AP Antonio, GE Wong, KT Chan, DPN Ng, AWH Shing, KK Chau, SSL Mak, P Chan, P Ahuja, AT Hui, DS Sung, JJY Rainer, TH	3-Jun-2006
Mapping the functional assessment of cancer therapy-general or -colorectal to preference-based values measured by SF-6D in patients with colorectal neoplasm Proceeding/Conference:Annual Conference of the International Society of Quality of Life Research, ISOQOL 2011	Wong, CKH Lam, CLK McGhee, SM Law, WL Poon, TCJ Chan, P Kwong, DLW Tsang, J Rowen, DL	2011
A multi-center phase II trial of bevacizumab (B) pre- and post-transarterial chemoembolization (TACE) treatment for patients with localized unresectable HCC: interim safety report Proceeding/Conference:Hepatology	Poon, R Yau, T Chan, P Tai, KS Cheung, TT Chan, A Kwok, PC Jin, K Lee, KF Lai, PB	2010
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study Proceeding/Conference:Journal of Clinical Oncology	Yau, TCC Cheung, FY Lee, F Choo, SP Wong, HYH Toh, HC Leung, AK Chan, P Yau, TK Wong, J Tang, YF Lau, JSM Cheung, TT Fan, ST Poon, RTP	2013
Patients with coronary artery disease had high prevalanece of colorectal cancer and adenoma: END-results of metabolic syndrome and smoking Proceeding/Conference:Gastroenterology	Chan, AOO Jim, MH Lam, KF Siu, DCW Tong, SM Ng, FH Wong, SY Hui, WM Chan, CK Lai, KC Cheung, TK Chan, P Wong, G Yuen, RMF Lau, YK Lee, SWL Seto, ML Lam, SK Wong, BCY	2007
A phase I study of recombinant human arginase I (rhArgI) for patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology	Yau, CC Chan, P Pang, R Chan, W Cheng, PN Poon, R	2010
Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma Proceeding/Conference:European Journal of Cancer Supplements	Yau, TCC Chan, P Cheung, FY Lee, AS Yau, TK Choo, SP Lau, J Wong, JS Fan, ST Poon, RTP	2009
A pilot study on validation of traditional Chinese FACT-C on patients with colorectal neoplasm Proceeding/Conference:Quality of Life Research	Wong, CKH Lam, CLK Law, WL Poon, JTC Chan, P	2010
Predictability of in-brace correction and Cobb's Angle at Brace Weaning using supine radiographs for adolescent idiopathic scoliosis Proceeding/Conference:Annual Congress of the Hong Kong Orthopaedic Association, HKOA 2016	Cheung, JPY Yiu, KL Chan, P Cheung, WHP Luk, KDK Cheung, KMC	2016
Prenatal Antidepressant Exposure and the Risk of Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder Proceeding/Conference:International Conference on Pharmacoepidemiology & Therapeutic Risk Management, ICPE 2015	Man, KKC Chan, EW Coghill, DR Ip, P Simonoff, E Chan, P Lau, WCY Wong, ICK	2015

Showing results 1 to 20 of 25 next >